Loading...

TechCare

OTCPK:TECR
Snowflake Description

Mediocre balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TECR
OTCPK
$8M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

TechCare Corp., a technology company, engages in the design, development, and commercialization of a platform utilizing proprietary vaporization technology to enable health, wellness, and beauty treatments in the Netherlands and Israel. The last earnings update was 10 days ago. More info.


Add to Portfolio Compare Print
  • TechCare has significant price volatility in the past 3 months.
TECR Share Price and Events
7 Day Returns
38.3%
OTCPK:TECR
-0.3%
US Medical Equipment
0.2%
US Market
1 Year Returns
-46.7%
OTCPK:TECR
10.1%
US Medical Equipment
2.9%
US Market
TECR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
TechCare (TECR) 38.3% 58.8% 195.5% -46.7% - -
US Medical Equipment -0.3% 3.2% -1% 10.1% 55.2% 90.1%
US Market 0.2% -1.6% 2.4% 2.9% 36.1% 41%
1 Year Return vs Industry and Market
  • TECR underperformed the Medical Equipment industry which returned 10.1% over the past year.
  • TECR underperformed the Market in United States of America which returned 2.9% over the past year.
Price Volatility
TECR
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for TechCare's competitors could be found in our database.

Value

 Is TechCare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for TechCare. This is due to cash flow or dividend data being unavailable. The share price is $0.23995.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for TechCare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are TechCare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:TECR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.07
OTCPK:TECR Share Price ** OTCPK (2019-05-23) in USD $0.24
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 38.96x
United States of America Market PE Ratio Median Figure of 3,085 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of TechCare.

OTCPK:TECR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:TECR Share Price ÷ EPS (both in USD)

= 0.24 ÷ -0.07

-3.57x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TechCare is loss making, we can't compare its value to the US Medical Equipment industry average.
  • TechCare is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does TechCare's expected growth come at a high price?
Raw Data
OTCPK:TECR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.57x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.15x
United States of America Market PEG Ratio Median Figure of 2,123 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for TechCare, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on TechCare's assets?
Raw Data
OTCPK:TECR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.02
OTCPK:TECR Share Price * OTCPK (2019-05-23) in USD $0.24
United States of America Medical Equipment Industry PB Ratio Median Figure of 182 Publicly-Listed Medical Equipment Companies 4.48x
United States of America Market PB Ratio Median Figure of 5,201 Publicly-Listed Companies 1.84x
OTCPK:TECR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:TECR Share Price ÷ Book Value per Share (both in USD)

= 0.24 ÷ 0.02

13.83x

* Primary Listing of TechCare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TechCare is overvalued based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess TechCare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. TechCare has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is TechCare expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TechCare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.9%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is TechCare expected to grow at an attractive rate?
  • Unable to compare TechCare's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare TechCare's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare TechCare's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:TECR Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.9%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:TECR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:TECR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 0 -2 -2
2018-12-31 0 -2 -2
2018-09-30 0 -2 -2
2018-06-30 0 -2 -2
2018-03-31 0 -2 -2
2017-12-31 -1 -3
2017-09-30 -1 -3
2017-06-30 -1 -3
2017-03-31 -1 -3
2016-12-31 -1 -2
2016-09-30 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if TechCare is high growth as no earnings estimate data is available.
  • Unable to determine if TechCare is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:TECR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from TechCare Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:TECR Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.07
2018-12-31 -0.07
2018-09-30 -0.06
2018-06-30 -0.06
2018-03-31 -0.07
2017-12-31 -0.12
2017-09-30 -0.14
2017-06-30 -0.17
2017-03-31 -0.16
2016-12-31 -0.11
2016-09-30 -0.14

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if TechCare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of TECR’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. TechCare's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access TechCare's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess TechCare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
TechCare has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has TechCare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare TechCare's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • TechCare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare TechCare's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare TechCare's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
TechCare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from TechCare Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:TECR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 0.28 -2.27 2.00 0.28
2018-12-31 0.25 -2.16 2.03 0.27
2018-09-30 0.19 -1.87 1.89 0.19
2018-06-30 0.10 -1.60 1.82 0.07
2018-03-31 0.03 -1.76 1.63 0.14
2017-12-31 -2.86 2.48 0.27
2017-09-30 -2.90 2.02 0.29
2017-06-30 -3.40 2.11 0.57
2017-03-31 -2.97 1.86 0.66
2016-12-31 -1.85 0.57 0.81
2016-09-30 -2.07 0.91 1.08
2016-03-31 -1.09 0.34 0.71
2015-12-31 -0.77 0.33 0.40
2014-12-31 -0.59 0.08 0.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if TechCare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if TechCare has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if TechCare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess TechCare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
TechCare has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is TechCare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up TechCare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • TechCare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • TechCare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of TechCare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 3.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from TechCare Company Filings, last reported 1 month ago.

OTCPK:TECR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 0.59 0.19 0.37
2018-12-31 0.74 0.08 0.47
2018-09-30 0.65 0.08 0.38
2018-06-30 0.61 0.08 0.45
2018-03-31 1.06 0.08 0.95
2017-12-31 0.51 0.09 0.59
2017-09-30 -0.06 0.09 0.08
2017-06-30 0.11 0.09 0.30
2017-03-31 0.66 0.08 0.57
2016-12-31 0.11 0.08 0.28
2016-09-30 0.34 0.08 0.69
2016-03-31 -0.01 0.08 0.17
2015-12-31 0.06 0.18 0.25
2014-12-31 -0.06 0.23 0.25
  • TechCare's level of debt (32.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if TechCare's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • TechCare has less than a year of cash runway based on current free cash flow.
  • TechCare has less than a year of cash runway if free cash flow continues to grow at historical rates of 29.7% each year.
X
Financial health checks
We assess TechCare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. TechCare has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is TechCare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from TechCare dividends.
If you bought $2,000 of TechCare shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate TechCare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate TechCare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:TECR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2005 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as TechCare has not reported any payouts.
  • Unable to verify if TechCare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of TechCare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as TechCare has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess TechCare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can TechCare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. TechCare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of TechCare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Zvi Yemini
COMPENSATION $140,537
AGE 67
TENURE AS CEO 0.2 years
CEO Bio

Mr. Zvika Yemini, also known as Zvi, is Co-Owner of YMY Ltd. Mr. Yemini has been the Chairman of TechCare Corp. since August 17, 2016 and has been its Chief Executive Officer since March 1, 2019. Mr. Yemini served as Chief Executive Officer of TechCare Corp. since June 05, 2018 until July 15, 2018 and also from October 2016 until August 2017. Mr. Yemini founded The Stanley Works Israel Ltd. in 1987 and serves as its Chairman. He founded ZAG Industries Ltd. (ZAG was acquired by Stanley) in 1987 and served as its Chief Executive Officer until 2000 and its Chairman until 2006. Mr. Yemini has over 25 years of industry experience. He co-founded Hydro Industries Ltd. in 2002 and served as its Chairman from 2002 to 2011. He has been the Chairman of Shenkar Design College since 2011 and Tel-Aviv Trade Fairs & Convention Center since 2002. He served as Non-executive Chairman of the Board of Directors of Polymer Logistics N.V. He served as an Independent Director of Nano Dimension Ltd. from January 28, 2015 to April 24, 2017. He served as a Non-Executive Director of Polymer Logistics N.V. since January 1, 1999. He is Winner of the 2001 Industrial Award, the 2000 Israel Export Award and the 1998 Kaplan Award. Mr. Yemini holds B.A in Industrial Engineering from the Technion Israel Institute of Technology and an Executive M.B.A. from Tel-Aviv University and M.A. in Marketing from Baruch College in New York.

CEO Compensation
  • Zvi's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Zvi's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure of the TechCare management team in years:

1.8
Average Tenure
  • The average tenure for the TechCare management team is less than 2 years, this suggests a new team.
Management Team

Zvi Yemini

TITLE
Chairman & CEO
COMPENSATION
$141K
AGE
67
TENURE
0.2 yrs

Tali Dinar

TITLE
Chief Financial Officer
AGE
46
TENURE
0.3 yrs

Tabe Ydo

TITLE
Chief Marketing Officer
TENURE
1.8 yrs

Michel Bergh

TITLE
Chief Commercial Officer
TENURE
1.8 yrs

Laurence Alexander

TITLE
European Chief Executive Officer
TENURE
1.8 yrs
Board of Directors Tenure

Average tenure and age of the TechCare board of directors in years:

2
Average Tenure
60.5
Average Age
  • The average tenure for the TechCare board of directors is less than 3 years, this suggests a new board.
Board of Directors

Zvi Yemini

TITLE
Chairman & CEO
COMPENSATION
$141K
AGE
67
TENURE
2.8 yrs

Oren Traistman

TITLE
Director
COMPENSATION
$33K
AGE
48
TENURE
2.6 yrs

Yossef De-Levy

TITLE
Director
COMPENSATION
$32K
AGE
66
TENURE
2.6 yrs

Nava Ravid

TITLE
Member of Advisory Board
TENURE
2 yrs

Michael Samish

TITLE
Member of Advisory Board
TENURE
2 yrs

Uri Stoin

TITLE
Member of Advisory Board
TENURE
2 yrs

George Pehlivanian

TITLE
Member of Advisory Board
TENURE
2 yrs

Ningzhou Zhang

TITLE
Director
AGE
55
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
30. Apr 19 Buy Traistman Radziejewski Fundacja Ltd. Company 28. Apr 19 28. Apr 19 546,448 $0.18 $100,000
30. Apr 19 Buy Microdel Ltd. Company 28. Apr 19 28. Apr 19 136,612 $0.18 $25,000
24. Apr 19 Buy Traistman Radziejewski Fundacja Ltd. Company 17. Nov 17 08. Aug 18 481,612 $0.39 $150,000
24. Apr 19 Buy Zvi Yemini Individual 14. Nov 17 28. Oct 18 2,744,568 $0.51 $650,510
24. Apr 19 Buy Zvi Yemini Individual 09. Jan 17 08. Aug 18 1,165,993 $0.48 $350,295
24. Apr 19 Buy Marius Nacht Individual 14. Nov 18 14. Nov 18 1,915,708 $0.26 $500,000
X
Management checks
We assess TechCare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. TechCare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

TechCare Corp., a technology company, engages in the design, development, and commercialization of a platform utilizing proprietary vaporization technology to enable health, wellness, and beauty treatments in the Netherlands and Israel. Its products include Novokid, a device for the treatment of head lice and eggs; and Shine, a device for the treatment and rejuvenation of the hair and scalp. The company is headquartered in Rosh HaAyin, Israel.

Details
Name: TechCare Corp.
TECR
Exchange: OTCPK
Founded:
$8,199,065
34,169,890
Website: http://www.techcareltd.com
Address: TechCare Corp.
23 Hamelacha Street,
Park Afek,
Rosh HaAyin,
Israel
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK TECR New Common Stock Pink Sheets LLC US USD 01. Aug 2016
BST 1PR1 New Common Stock Boerse-Stuttgart DE EUR 01. Aug 2016
Number of employees
Current staff
Staff numbers
10
TechCare employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/24 00:46
End of day share price update: 2019/05/23 00:00
Last earnings filing: 2019/05/14
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.